NO20081727L - Behandling av autoimmune sykdommer - Google Patents

Behandling av autoimmune sykdommer

Info

Publication number: NO20081727L
Authority: NO; Norway
Prior art keywords: autoimmune diseases; treatment; neuritis; uveitis; methods
Prior art date: 2005-09-09

Application number

NO20081727A

Other languages

English (en)

Norwegian (no)

Inventor

Rainer Albert

Nigel Graham Cooke

Sven Weiler

Barbara Nuesslein-Hildesheim

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-09

Filing date

2008-04-07

Publication date

2008-06-06

2008-04-07 Application filed by Novartis Ag filed Critical Novartis Ag

2008-06-06 Publication of NO20081727L publication Critical patent/NO20081727L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20081727A 2005-09-09 2008-04-07 Behandling av autoimmune sykdommer NO20081727L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71599005P	2005-09-09	2005-09-09
PCT/EP2006/066150 WO2007028821A2 (en)	2005-09-09	2006-09-07	Treatment of autoimmune diseases

Publications (1)

Publication Number	Publication Date
NO20081727L true NO20081727L (no)	2008-06-06

Family

ID=37056992

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081727A NO20081727L (no)	2005-09-09	2008-04-07	Behandling av autoimmune sykdommer

Country Status (28)

Country	Link
US (1)	US20080200438A1 (es)
EP (2)	EP1926483B1 (es)
JP (4)	JP5244598B2 (es)
KR (3)	KR101476591B1 (es)
CN (1)	CN101257899B (es)
AT (1)	ATE489948T1 (es)
AU (2)	AU2006289100B2 (es)
BR (1)	BRPI0615906A2 (es)
CA (2)	CA2620554C (es)
CY (1)	CY1111285T1 (es)
DE (1)	DE602006018629D1 (es)
DK (2)	DK2295049T3 (es)
ES (2)	ES2357426T3 (es)
IL (2)	IL189665A (es)
JO (1)	JO2655B1 (es)
MA (1)	MA29787B1 (es)
MX (1)	MX2008003170A (es)
NO (1)	NO20081727L (es)
NZ (2)	NZ566137A (es)
PL (2)	PL1926483T3 (es)
PT (2)	PT2295049E (es)
RU (2)	RU2493840C2 (es)
SG (1)	SG165364A1 (es)
SI (2)	SI1926483T1 (es)
TN (1)	TNSN08103A1 (es)
TW (2)	TWI372620B (es)
WO (1)	WO2007028821A2 (es)
ZA (1)	ZA200801694B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1772145B1 (en)	2004-07-16	2011-03-23	Kyorin Pharmaceutical Co., Ltd.	Method of effectively using medicine and method concerning prevention of side effect
ES2615498T3 (es)	2004-10-12	2017-06-07	Kyorin Pharmaceutical Co., Ltd.	Procedimiento para producir hidrocloruro de 2-amino-2-[2-[4-(3-benciloxifeniltio)-2-clorofenil]etil]-1,3-propanodiol
KR101297302B1 (ko) *	2005-10-07	2013-08-19	교린 세이야꾸 가부시키 가이샤	2-아미노-1,3-프로판디올 유도체를 유효성분으로 하는간장질환 치료제 및 간장질환 치료방법
TWI389683B (zh) *	2006-02-06	2013-03-21	Kyorin Seiyaku Kk	A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
PL2058317T3 (pl) *	2006-08-08	2014-03-31	Kyorin Seiyaku Kk	Aminowa pochodna estru kwasu fosforowego i modulator receptora S1P zawierający ją jako składnik aktywny
WO2008018447A1 (en) *	2006-08-08	2008-02-14	Kyorin Pharmaceutical Co., Ltd.	Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
JP5198293B2 (ja) *	2007-02-13	2013-05-15	杏林製薬株式会社	アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
JP5452237B2 (ja)	2008-02-07	2014-03-26	杏林製薬株式会社	アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤
RU2505288C2 (ru) *	2008-05-20	2014-01-27	Киорин Фармасьютикал Ко., Лтд.	Средства поддержания индуцированной ремиссии
CN102119028A (zh) *	2008-08-18	2011-07-06	诺瓦提斯公司	用于治疗脱髓鞘性周围神经病的氨基醇衍生物
BR112012028190A2 (pt) *	2010-05-06	2016-08-02	Novartis Ag	tratamento de doenças autoimunes
EP2566473B1 (en) *	2010-05-06	2016-01-06	Novartis AG	Dosage regimen of diaryl sulfide derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141421A (en) *	1991-12-17	1992-08-25	Carrier Corporation	Nested coupling mechanism for scroll machines
DE4428835A1 (de) *	1994-08-01	1996-02-08	Schering Ag	Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
KR20000075745A (ko) *	1997-02-27	2000-12-26	가마후라 아키오	의약 조성물
CA2461212C (en) *	2001-09-27	2010-08-17	Kyorin Pharmaceutical Co., Ltd.	Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
US6963012B2 (en) *	2001-09-27	2005-11-08	Kyorin Pharmaceutical Co., Ltd.	Diaryl ether derivative, addition salt thereof, and immunosuppressant
BR0314455A (pt) *	2002-09-19	2005-07-26	Kyorin Seiyaku Kk	Derivados de aminoálcool, seus sais e agentes imunosupressores
TWI335311B (en) *	2002-09-24	2011-01-01	Novartis Ag	Organic compounds
CA2499882C (en) *	2002-09-28	2010-11-09	Mcneil-Ppc, Inc.	Modified release dosage form with two cores
CN100344638C (zh) *	2003-02-18	2007-10-24	杏林制药株式会社	氨基膦酸衍生物、其加成盐以及s1p受体调节剂
KR101367574B1 (ko) *	2003-04-08	2014-02-25	미쓰비시 타나베 파마 코퍼레이션	Ｓ1ｐ 수용체 아고니스트 및 당 알콜을 포함하는 고형 제약 조성물
TW200505416A (en) *	2003-08-12	2005-02-16	Mitsubishi Pharma Corp	Bi-aryl compound having immunosuppressive activity
ATE449069T1 (de) *	2003-08-28	2009-12-15	Novartis Pharma Gmbh	Aminopropanolderivate
EP1772145B1 (en) *	2004-07-16	2011-03-23	Kyorin Pharmaceutical Co., Ltd.	Method of effectively using medicine and method concerning prevention of side effect
KR20130041385A (ko) *	2004-11-29	2013-04-24	노파르티스 아게	Ｓ１ｐ 수용체 효능제의 투여 용법
GB0504544D0 (en) *	2005-03-04	2005-04-13	Novartis Ag	Organic compounds

2006
- 2006-09-07 CA CA2620554A patent/CA2620554C/en not_active Expired - Fee Related
- 2006-09-07 PL PL06793341T patent/PL1926483T3/pl unknown
- 2006-09-07 RU RU2011111117/15A patent/RU2493840C2/ru not_active IP Right Cessation
- 2006-09-07 JO JO2006298A patent/JO2655B1/en active
- 2006-09-07 DE DE602006018629T patent/DE602006018629D1/de active Active
- 2006-09-07 JP JP2008529636A patent/JP5244598B2/ja active Active
- 2006-09-07 WO PCT/EP2006/066150 patent/WO2007028821A2/en not_active Ceased
- 2006-09-07 PL PL10174280T patent/PL2295049T3/pl unknown
- 2006-09-07 EP EP06793341A patent/EP1926483B1/en active Active
- 2006-09-07 SI SI200630937T patent/SI1926483T1/sl unknown
- 2006-09-07 CA CA2820510A patent/CA2820510A1/en not_active Abandoned
- 2006-09-07 RU RU2008113187/15A patent/RU2424795C2/ru not_active IP Right Cessation
- 2006-09-07 PT PT10174280T patent/PT2295049E/pt unknown
- 2006-09-07 AU AU2006289100A patent/AU2006289100B2/en not_active Ceased
- 2006-09-07 KR KR1020147001496A patent/KR101476591B1/ko not_active Expired - Fee Related
- 2006-09-07 DK DK10174280.7T patent/DK2295049T3/en active
- 2006-09-07 KR KR1020147026128A patent/KR20140117704A/ko not_active Ceased
- 2006-09-07 BR BRPI0615906-0A patent/BRPI0615906A2/pt not_active IP Right Cessation
- 2006-09-07 ES ES06793341T patent/ES2357426T3/es active Active
- 2006-09-07 MX MX2008003170A patent/MX2008003170A/es active IP Right Grant
- 2006-09-07 SG SG201006580-3A patent/SG165364A1/en unknown
- 2006-09-07 AT AT06793341T patent/ATE489948T1/de active
- 2006-09-07 SI SI200631889T patent/SI2295049T1/sl unknown
- 2006-09-07 ES ES10174280.7T patent/ES2529724T3/es active Active
- 2006-09-07 CN CN2006800328984A patent/CN101257899B/zh not_active Expired - Fee Related
- 2006-09-07 NZ NZ566137A patent/NZ566137A/en not_active IP Right Cessation
- 2006-09-07 PT PT06793341T patent/PT1926483E/pt unknown
- 2006-09-07 US US12/065,096 patent/US20080200438A1/en not_active Abandoned
- 2006-09-07 EP EP10174280.7A patent/EP2295049B1/en not_active Not-in-force
- 2006-09-07 NZ NZ588372A patent/NZ588372A/en not_active IP Right Cessation
- 2006-09-07 DK DK06793341.6T patent/DK1926483T3/da active
- 2006-09-08 TW TW099117063A patent/TWI372620B/zh not_active IP Right Cessation
- 2006-09-08 TW TW095133326A patent/TWI376223B/zh active
2008
- 2008-02-21 ZA ZA200801694A patent/ZA200801694B/xx unknown
- 2008-02-21 IL IL189665A patent/IL189665A/en not_active IP Right Cessation
- 2008-03-06 TN TNP2008000103A patent/TNSN08103A1/en unknown
- 2008-03-17 MA MA30758A patent/MA29787B1/fr unknown
- 2008-04-07 NO NO20081727A patent/NO20081727L/no not_active Application Discontinuation
- 2008-04-08 KR KR1020087008413A patent/KR101476451B1/ko not_active Expired - Fee Related
2010
- 2010-09-21 AU AU2010224355A patent/AU2010224355B2/en not_active Ceased
2011
- 2011-03-01 CY CY20111100242T patent/CY1111285T1/el unknown
2012
- 2012-10-17 JP JP2012230044A patent/JP6077265B2/ja not_active Expired - Fee Related
2014
- 2014-06-23 IL IL233328A patent/IL233328A0/en unknown
- 2014-09-29 JP JP2014199069A patent/JP2015025002A/ja not_active Withdrawn
2016
- 2016-09-30 JP JP2016193400A patent/JP2017019854A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2820510A1 (en)	2007-03-15
ES2529724T3 (es)	2015-02-25
HK1149906A1 (en)	2011-10-21
CA2620554C (en)	2013-12-17
EP2295049A1 (en)	2011-03-16
KR101476591B1 (ko)	2014-12-24
US20080200438A1 (en)	2008-08-21
RU2011111117A (ru)	2012-09-27
AU2006289100B2 (en)	2010-07-22
JP2017019854A (ja)	2017-01-26
WO2007028821A3 (en)	2007-05-03
MA29787B1 (fr)	2008-09-01
PL2295049T3 (pl)	2015-04-30
MX2008003170A (es)	2008-03-18
JP6077265B2 (ja)	2017-02-08
ZA200801694B (en)	2009-09-30
TW200803829A (en)	2008-01-16
RU2008113187A (ru)	2009-10-20
BRPI0615906A2 (pt)	2011-05-31
KR101476451B1 (ko)	2014-12-24
KR20140019033A (ko)	2014-02-13
PT2295049E (pt)	2015-03-02
AU2010224355B2 (en)	2012-03-29
JP2013010802A (ja)	2013-01-17
DK1926483T3 (da)	2011-03-14
IL189665A0 (en)	2008-06-05
TNSN08103A1 (en)	2009-07-14
PT1926483E (pt)	2011-03-03
AU2006289100A1 (en)	2007-03-15
ATE489948T1 (de)	2010-12-15
EP2295049B1 (en)	2014-11-26
TWI372620B (en)	2012-09-21
TWI376223B (en)	2012-11-11
DE602006018629D1 (de)	2011-01-13
SI1926483T1 (sl)	2011-04-29
CA2620554A1 (en)	2007-03-15
NZ566137A (en)	2011-05-27
DK2295049T3 (en)	2015-02-23
JP2015025002A (ja)	2015-02-05
WO2007028821A2 (en)	2007-03-15
EP1926483A2 (en)	2008-06-04
ES2357426T3 (es)	2011-04-26
PL1926483T3 (pl)	2011-05-31
KR20140117704A (ko)	2014-10-07
EP1926483B1 (en)	2010-12-01
TW201034659A (en)	2010-10-01
IL189665A (en)	2014-07-31
JO2655B1 (en)	2012-06-17
NZ588372A (en)	2012-03-30
JP5244598B2 (ja)	2013-07-24
IL233328A0 (en)	2014-08-31
CN101257899A (zh)	2008-09-03
RU2493840C2 (ru)	2013-09-27
AU2010224355A1 (en)	2010-10-14
RU2424795C2 (ru)	2011-07-27
SG165364A1 (en)	2010-10-28
KR20080046231A (ko)	2008-05-26
JP2009507810A (ja)	2009-02-26
CN101257899B (zh)	2012-10-03
CY1111285T1 (el)	2015-08-05
SI2295049T1 (sl)	2015-03-31

Publication	Publication Date	Title
NO20081727L (no)	2008-06-06	Behandling av autoimmune sykdommer
NO20054407L (no)	2005-12-15	Cannabinoid reseptor ligander og deres anvendelser
NO20083002L (no)	2008-08-14	Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20072092L (no)	2007-06-22	Sulfonamidforbindelser
NO20081788L (no)	2008-05-29	Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
NO20070908L (no)	2007-03-14	Sammensmeltede ringheterocykelkinasemodulatorer
NO20076401L (no)	2008-02-08	Diarylhydantoinforbindelser
MX2009011210A (es)	2009-10-30	Inhibidores de mcl1 de indol 7-no sustituido.
DK2023918T3 (da)	2011-04-26	Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
MX2009011211A (es)	2009-10-30	Indoles sustituidos en la posicion 7 inhibidores de mci-1.
ATE493418T1 (de)	2011-01-15	Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
EA200702048A1 (ru)	2008-04-28	Фармакокинетически улучшенные соединения
DK2054418T3 (da)	2012-02-27	Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
ECSP088561A (es)	2008-07-30	Derivados de pirimidinil-aril-urea que son inhibidores de fgf
NO20076412L (no)	2008-01-14	Heterosykliske inhibitorer av mek og fremgangsmater for anvendelse derav
NO20080318L (no)	2008-04-02	Anvendelse av enkelt dose av CD-20-spesifikke bindingsmolekyler
TW200509892A (en)	2005-03-16	Novel aminobenzophenone compounds
NO20053042L (no)	2005-06-21	Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
ATE472529T1 (de)	2010-07-15	Prolinamidderivate als natriumkanalmodulatoren
IL189286A0 (en)	2008-06-05	Novel cysteine protease inhibitors and their therapeutic applications
WO2006079057A3 (en)	2007-02-01	Methods and compositions for specific inhibition of protein splicing by small molecules
TW200639155A (en)	2006-11-16	Thiazolidinones, their production and use as pharmaceutical agents
WO2006034391A3 (en)	2006-08-03	Indole inhibitors of 15-lipoxygenase
MX2007013306A (es)	2007-12-13	Nuevas tiazolidinonas sin nitrogeno basico, su produccion y su uso como agentes farmaceuticos.
WO2025188662A8 (en)	2025-10-02	Akt1 modulators

Legal Events

Date	Code	Title	Description
2016-04-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application